Loading…

Uptake and metabolism of iproplatin in murine L1210 cells

Iproplatin is structurally unique among the platinum (Pt) agents in the clinic because it is a quadrivalent complex. On the basis of the redox parameters for the Pt(IV) and Pt(II) oxidation states in a chloride system, it has been suggested that Pt(IV) complexes will be reduced to Pt(II) complexes i...

Full description

Saved in:
Bibliographic Details
Published in:Cancer chemotherapy and pharmacology 1989, Vol.25 (1), p.15-18
Main Authors: PENDYALA, L, WALSH, J. R, HUQ, M. M, ARAKALI, A. V, COWENS, J. W, CREAVEN, P. J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c311t-1063922b66a538656f659c766d0706afb8e9ef8d2cdbedfb6ae4a0cbf72eec613
cites cdi_FETCH-LOGICAL-c311t-1063922b66a538656f659c766d0706afb8e9ef8d2cdbedfb6ae4a0cbf72eec613
container_end_page 18
container_issue 1
container_start_page 15
container_title Cancer chemotherapy and pharmacology
container_volume 25
creator PENDYALA, L
WALSH, J. R
HUQ, M. M
ARAKALI, A. V
COWENS, J. W
CREAVEN, P. J
description Iproplatin is structurally unique among the platinum (Pt) agents in the clinic because it is a quadrivalent complex. On the basis of the redox parameters for the Pt(IV) and Pt(II) oxidation states in a chloride system, it has been suggested that Pt(IV) complexes will be reduced to Pt(II) complexes in a biological environment. To test this hypothesis, uptake and metabolism studies of [14C]-iproplatin were carried out in L1210 cells. The L1210 cells raised in DBA2/J mice were incubated in vitro with 50 and 100 microM [14C]-iproplatin at 37 degrees C in Hanks' balanced salt solution, and total uptake and radioactivity associated with acid-insoluble fractions were measured for up to 3 h. Under these conditions, the uptake of iproplatin was linear with time and increased with increasing concentrations of iproplatin in the medium. At all times measured, greater than 35% of radioactivity was associated with the acid-insoluble fraction, suggesting binding to macromolecules. The [14C]-labelled compounds in neutralized acid extracts of cells were separated by reverse-phase high-performance liquid chromatography (HPLC). Three labelled compounds were detected; based on chromatographic elution times, they appeared to be iproplatin, cis-dichloro-bis-isopropylamine platinum(II) (CIP), the reduction product of iproplatin, and a third compound more polar than iproplatin and CIP. The finding of free CIP and the macromolecular binding of radioactivity in the cells suggests that iproplatin is reduced intracellularly.
doi_str_mv 10.1007/BF00694332
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79360267</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79360267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-1063922b66a538656f659c766d0706afb8e9ef8d2cdbedfb6ae4a0cbf72eec613</originalsourceid><addsrcrecordid>eNpFkEtLw0AUhQdRaq1u3AtZiAsheueRO5mlFqtCwY1dh8nkDkTzMpMs_PemNFS4cBfn43D4GLvm8MAB9OPzBgCNklKcsCVXUsSQKnnKliCVihMN6pxdhPAFAIpLuWALkRgwRi-Z2XWD_abINkVU02DztipDHbU-Kru-7So7lE00XT32ZUPRlgsOkaOqCpfszNsq0NX8V2y3eflcv8Xbj9f39dM2dpLzIeaA0giRI9pEppigx8Q4jViABrQ-T8mQTwvhipwKn6MlZcHlXgsih1yu2N2hd9rzM1IYsroM-wW2oXYMmTYSQaCewPsD6Po2hJ581vVlbfvfjEO295T9e5rgm7l1zGsqjugsZspv59wGZyvf28aV4YghppimRv4Brmdtlg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79360267</pqid></control><display><type>article</type><title>Uptake and metabolism of iproplatin in murine L1210 cells</title><source>Springer LINK Archives</source><creator>PENDYALA, L ; WALSH, J. R ; HUQ, M. M ; ARAKALI, A. V ; COWENS, J. W ; CREAVEN, P. J</creator><creatorcontrib>PENDYALA, L ; WALSH, J. R ; HUQ, M. M ; ARAKALI, A. V ; COWENS, J. W ; CREAVEN, P. J</creatorcontrib><description>Iproplatin is structurally unique among the platinum (Pt) agents in the clinic because it is a quadrivalent complex. On the basis of the redox parameters for the Pt(IV) and Pt(II) oxidation states in a chloride system, it has been suggested that Pt(IV) complexes will be reduced to Pt(II) complexes in a biological environment. To test this hypothesis, uptake and metabolism studies of [14C]-iproplatin were carried out in L1210 cells. The L1210 cells raised in DBA2/J mice were incubated in vitro with 50 and 100 microM [14C]-iproplatin at 37 degrees C in Hanks' balanced salt solution, and total uptake and radioactivity associated with acid-insoluble fractions were measured for up to 3 h. Under these conditions, the uptake of iproplatin was linear with time and increased with increasing concentrations of iproplatin in the medium. At all times measured, greater than 35% of radioactivity was associated with the acid-insoluble fraction, suggesting binding to macromolecules. The [14C]-labelled compounds in neutralized acid extracts of cells were separated by reverse-phase high-performance liquid chromatography (HPLC). Three labelled compounds were detected; based on chromatographic elution times, they appeared to be iproplatin, cis-dichloro-bis-isopropylamine platinum(II) (CIP), the reduction product of iproplatin, and a third compound more polar than iproplatin and CIP. The finding of free CIP and the macromolecular binding of radioactivity in the cells suggests that iproplatin is reduced intracellularly.</description><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/BF00694332</identifier><identifier>PMID: 2590997</identifier><identifier>CODEN: CCPHDZ</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Animals ; Antineoplastic agents ; Antineoplastic Agents - analysis ; Antineoplastic Agents - pharmacokinetics ; Biological and medical sciences ; Carbon Radioisotopes ; Chromatography, High Pressure Liquid - methods ; Drug Stability ; General aspects ; Leukemia L1210 - metabolism ; Medical sciences ; Mice ; Mice, Inbred DBA ; Organoplatinum Compounds - analysis ; Organoplatinum Compounds - pharmacokinetics ; Pharmacology. Drug treatments ; Solubility ; Time Factors ; Tumor Cells, Cultured</subject><ispartof>Cancer chemotherapy and pharmacology, 1989, Vol.25 (1), p.15-18</ispartof><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-1063922b66a538656f659c766d0706afb8e9ef8d2cdbedfb6ae4a0cbf72eec613</citedby><cites>FETCH-LOGICAL-c311t-1063922b66a538656f659c766d0706afb8e9ef8d2cdbedfb6ae4a0cbf72eec613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6686889$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2590997$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PENDYALA, L</creatorcontrib><creatorcontrib>WALSH, J. R</creatorcontrib><creatorcontrib>HUQ, M. M</creatorcontrib><creatorcontrib>ARAKALI, A. V</creatorcontrib><creatorcontrib>COWENS, J. W</creatorcontrib><creatorcontrib>CREAVEN, P. J</creatorcontrib><title>Uptake and metabolism of iproplatin in murine L1210 cells</title><title>Cancer chemotherapy and pharmacology</title><addtitle>Cancer Chemother Pharmacol</addtitle><description>Iproplatin is structurally unique among the platinum (Pt) agents in the clinic because it is a quadrivalent complex. On the basis of the redox parameters for the Pt(IV) and Pt(II) oxidation states in a chloride system, it has been suggested that Pt(IV) complexes will be reduced to Pt(II) complexes in a biological environment. To test this hypothesis, uptake and metabolism studies of [14C]-iproplatin were carried out in L1210 cells. The L1210 cells raised in DBA2/J mice were incubated in vitro with 50 and 100 microM [14C]-iproplatin at 37 degrees C in Hanks' balanced salt solution, and total uptake and radioactivity associated with acid-insoluble fractions were measured for up to 3 h. Under these conditions, the uptake of iproplatin was linear with time and increased with increasing concentrations of iproplatin in the medium. At all times measured, greater than 35% of radioactivity was associated with the acid-insoluble fraction, suggesting binding to macromolecules. The [14C]-labelled compounds in neutralized acid extracts of cells were separated by reverse-phase high-performance liquid chromatography (HPLC). Three labelled compounds were detected; based on chromatographic elution times, they appeared to be iproplatin, cis-dichloro-bis-isopropylamine platinum(II) (CIP), the reduction product of iproplatin, and a third compound more polar than iproplatin and CIP. The finding of free CIP and the macromolecular binding of radioactivity in the cells suggests that iproplatin is reduced intracellularly.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - analysis</subject><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Carbon Radioisotopes</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Drug Stability</subject><subject>General aspects</subject><subject>Leukemia L1210 - metabolism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred DBA</subject><subject>Organoplatinum Compounds - analysis</subject><subject>Organoplatinum Compounds - pharmacokinetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Solubility</subject><subject>Time Factors</subject><subject>Tumor Cells, Cultured</subject><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><recordid>eNpFkEtLw0AUhQdRaq1u3AtZiAsheueRO5mlFqtCwY1dh8nkDkTzMpMs_PemNFS4cBfn43D4GLvm8MAB9OPzBgCNklKcsCVXUsSQKnnKliCVihMN6pxdhPAFAIpLuWALkRgwRi-Z2XWD_abINkVU02DztipDHbU-Kru-7So7lE00XT32ZUPRlgsOkaOqCpfszNsq0NX8V2y3eflcv8Xbj9f39dM2dpLzIeaA0giRI9pEppigx8Q4jViABrQ-T8mQTwvhipwKn6MlZcHlXgsih1yu2N2hd9rzM1IYsroM-wW2oXYMmTYSQaCewPsD6Po2hJ581vVlbfvfjEO295T9e5rgm7l1zGsqjugsZspv59wGZyvf28aV4YghppimRv4Brmdtlg</recordid><startdate>1989</startdate><enddate>1989</enddate><creator>PENDYALA, L</creator><creator>WALSH, J. R</creator><creator>HUQ, M. M</creator><creator>ARAKALI, A. V</creator><creator>COWENS, J. W</creator><creator>CREAVEN, P. J</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1989</creationdate><title>Uptake and metabolism of iproplatin in murine L1210 cells</title><author>PENDYALA, L ; WALSH, J. R ; HUQ, M. M ; ARAKALI, A. V ; COWENS, J. W ; CREAVEN, P. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-1063922b66a538656f659c766d0706afb8e9ef8d2cdbedfb6ae4a0cbf72eec613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - analysis</topic><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Carbon Radioisotopes</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Drug Stability</topic><topic>General aspects</topic><topic>Leukemia L1210 - metabolism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred DBA</topic><topic>Organoplatinum Compounds - analysis</topic><topic>Organoplatinum Compounds - pharmacokinetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Solubility</topic><topic>Time Factors</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PENDYALA, L</creatorcontrib><creatorcontrib>WALSH, J. R</creatorcontrib><creatorcontrib>HUQ, M. M</creatorcontrib><creatorcontrib>ARAKALI, A. V</creatorcontrib><creatorcontrib>COWENS, J. W</creatorcontrib><creatorcontrib>CREAVEN, P. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PENDYALA, L</au><au>WALSH, J. R</au><au>HUQ, M. M</au><au>ARAKALI, A. V</au><au>COWENS, J. W</au><au>CREAVEN, P. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uptake and metabolism of iproplatin in murine L1210 cells</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><addtitle>Cancer Chemother Pharmacol</addtitle><date>1989</date><risdate>1989</risdate><volume>25</volume><issue>1</issue><spage>15</spage><epage>18</epage><pages>15-18</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><coden>CCPHDZ</coden><abstract>Iproplatin is structurally unique among the platinum (Pt) agents in the clinic because it is a quadrivalent complex. On the basis of the redox parameters for the Pt(IV) and Pt(II) oxidation states in a chloride system, it has been suggested that Pt(IV) complexes will be reduced to Pt(II) complexes in a biological environment. To test this hypothesis, uptake and metabolism studies of [14C]-iproplatin were carried out in L1210 cells. The L1210 cells raised in DBA2/J mice were incubated in vitro with 50 and 100 microM [14C]-iproplatin at 37 degrees C in Hanks' balanced salt solution, and total uptake and radioactivity associated with acid-insoluble fractions were measured for up to 3 h. Under these conditions, the uptake of iproplatin was linear with time and increased with increasing concentrations of iproplatin in the medium. At all times measured, greater than 35% of radioactivity was associated with the acid-insoluble fraction, suggesting binding to macromolecules. The [14C]-labelled compounds in neutralized acid extracts of cells were separated by reverse-phase high-performance liquid chromatography (HPLC). Three labelled compounds were detected; based on chromatographic elution times, they appeared to be iproplatin, cis-dichloro-bis-isopropylamine platinum(II) (CIP), the reduction product of iproplatin, and a third compound more polar than iproplatin and CIP. The finding of free CIP and the macromolecular binding of radioactivity in the cells suggests that iproplatin is reduced intracellularly.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>2590997</pmid><doi>10.1007/BF00694332</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0344-5704
ispartof Cancer chemotherapy and pharmacology, 1989, Vol.25 (1), p.15-18
issn 0344-5704
1432-0843
language eng
recordid cdi_proquest_miscellaneous_79360267
source Springer LINK Archives
subjects Animals
Antineoplastic agents
Antineoplastic Agents - analysis
Antineoplastic Agents - pharmacokinetics
Biological and medical sciences
Carbon Radioisotopes
Chromatography, High Pressure Liquid - methods
Drug Stability
General aspects
Leukemia L1210 - metabolism
Medical sciences
Mice
Mice, Inbred DBA
Organoplatinum Compounds - analysis
Organoplatinum Compounds - pharmacokinetics
Pharmacology. Drug treatments
Solubility
Time Factors
Tumor Cells, Cultured
title Uptake and metabolism of iproplatin in murine L1210 cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A08%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uptake%20and%20metabolism%20of%20iproplatin%20in%20murine%20L1210%20cells&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=PENDYALA,%20L&rft.date=1989&rft.volume=25&rft.issue=1&rft.spage=15&rft.epage=18&rft.pages=15-18&rft.issn=0344-5704&rft.eissn=1432-0843&rft.coden=CCPHDZ&rft_id=info:doi/10.1007/BF00694332&rft_dat=%3Cproquest_cross%3E79360267%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c311t-1063922b66a538656f659c766d0706afb8e9ef8d2cdbedfb6ae4a0cbf72eec613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79360267&rft_id=info:pmid/2590997&rfr_iscdi=true